Articles

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions

Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Research and Non-clinical Development, CSL Vifor, St. Gallen
Haematologica Early view May 11, 2023 https://doi.org/10.3324/haematol.2022.282328